Acute interstitial nephritis (AIN) is a common cause of acute kidney injury. Many etiologies of AIN have been recognized—including allergic/drug-induced, infectious, autoimmune/systemic, and idiopathic forms of disease. The most common etiology of AIN is drug-induced disease, which is thought to underlie 60–70% of cases. Multiple agents from many different classes of drugs can cause AIN, and the clinical presentation and laboratory findings vary according to the class of drug involved. AIN is characterized by interstitial inflammation, tubulitis, edema, and in some cases, eventual interstitial fibrosis. A definitive diagnosis of AIN can be established only by kidney biopsy. Noninvasive tests such as 67gallium scintigraphy and testing for eosinophiluria have limited diagnostic utility. The mainstay of therapy for drug-induced AIN is timely discontinuation of the causative agent. Although the benefits of corticosteroid therapy remain unproven, they do appear to have a positive effect in some patients with drug-induced AIN, especially when treatment is initiated early in the course of the disease. In general, the prognosis for drug-induced AIN is good, and at least partial recovery of kidney function is normally observed. Early recognition is crucial because patients can ultimately develop chronic kidney disease.
Acute interstitial nephritis (AIN), which is primarily drug-induced, is a relatively common cause of acute kidney injury
The clinical presentation of AIN varies with the class of drug involved
A definitive diagnosis of AIN requires kidney biopsy because noninvasive laboratory tests and imaging studies lack sensitivity and specificity
Pathological findings in drug-induced AIN include interstitial inflammation, tubulitis, edema, and in some cases interstitial fibrosis
Corticosteroids may be beneficial to treat drug-induced AIN, especially when administered early in the course of disease
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Councilman, W. T. Acute interstitial nephritis. J. Exp. Med. 3, 393–420 (1898).
Cornell, L. D. et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am. J. Surg. Path. 31, 1586–1597 (2007).
Baldwin, D. S., Levine, B. B., McCluskey, R. T. & Gallo, G. R. Renal failure and interstitial nephritis due to penicillin and methicillin. N. Engl. J. Med. 279, 1245–1252 (1968).
Buysen, J. G., Houtlhoff, H. J., Krediet, R. T. & Arisz, L. Acute interstitial nephritis:a clinical and morphological study in 27 patients. Nephrol. Dial. Transplant. 5, 94–99 (1990).
Davison, A. M. & Jones, C. H. Acute interstitial nephritis in the elderly: A report from the UK MDC Glomerulonephritis Register and a review of the literature. Nephrol. Dial. Transplant. 13 (Suppl. 7), 12–16 (1998).
Clarkson, M. R. et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol. Dial. Transplant. 19, 2778–2783 (2004).
Farrington, K., Levison, D. A., Greenwood, R. N., Cattell, W. R. & Baker, L. R. Renal biopsy in patients with unexplained renal impairment and normal kidney size. Q. J. Med. 70, 221–233 (1989).
Baker, R. J. & Pusey, C. D. The changing profile of acute tubulointerstitial nephritis. Nephrol. Dial. Transplant. 19, 8–11 (2004).
Bijol, V., Mendez, G. P., Nose, V. & Rennke, H. G. Granulomatous interstitial nephritis: a clinicopathologic study of 46 cases from a single institution. Int. J. Surg. Pathol. 14, 57–63 (2006).
Michel, D. M. & Kelly, C. J. Acute interstitial nephritis. J. Am. Soc. Nephrol. 9, 506–515 (1998).
Kodner, C. M. & Kudrimoti, A. Diagnosis and management of acute interstitial nephritis. Am. Fam. Physician 67, 2527–2534 (2003).
Alexopoulos, E. Drug-induced acute interstitial nephritis. Ren. Fail. 20, 809–819 (1998).
Rossert, J. Drug-induced acute interstitial nephritis. Kidney Int. 60, 804–817 (2001).
Bhaumik, S. K. et al. Evaluation of clinical and histological prognostic markers in drug-induced acute interstitial nephritis. Ren. Fail. 18, 97–104 (1996).
Ooi, B. S., Jao, W., First, M. R., Mancilla, R. & Pollak, V. E. Acute interstitial nephritis. Am. J. Med. 59, 614–629 (1975).
Toto, R. D. Acute tubulointerstitial nephritis. Am. J. Med. Sci. 299, 392–410 (1990).
Mills, R. M. Severe hypersensitivity reactions associated with allopurinol. JAMA 216, 799–802 (1971).
Simenhoff, M. L., Guild, W. R. & Dammin, G. J. Acute diffuse intersitial nephritis: review of the literature and case report. Am. J. Med. 44, 618–625 (1968).
Baker, S. B. & Williams, R. T. Acute interstitial nephritis due to drug sensitivity. Br. Med. J. 1, 1655–1658 (1963).
Corwin, H. L., Korbet, S. M. & Schwartz, M. M. Clinical correlates of eosinophiluria. Arch. Intern. Med. 145, 1097–1099 (1985).
Ditlove, J., Weidmann, P., Bernstein, M. & Massry, S. G. Methicillin nephritis. Medicine (Baltimore) 56, 483–491 (1977).
Linton, A. L., Clark, W. F., Driedger, A. A., Turnbull, I. & Lindsay, R. M. Acute interstitial nephritis due to drugs. Ann. Intern. Med. 93, 735–741 (1980).
Nolan, C. R., Anger, M. S. & Kelleher, S. P. Eosinophiluria: a new detection and definition of the clinical spectrum. N. Engl. J. Med. 315, 1516–1519 (1986).
Corwin, H. L., Bray, R. A. & Haber, M. H. The detection and interpretation of urinary eosinophils. Arch. Pathol. Lab. Med. 113, 1256–1258 (1989).
Ruffing, K. A. et al. Eosinophils in urine revisited. Clin. Nephrol. 41, 163–166 (1994).
Koselj, M., Kveder, R., Bren, A. F. & Rott, T. Acute renal failure in patients with drug-induced acute interstitial nephritis. Ren. Fail. 15, 69–72 (1993).
D'Agati, V. D., Theise, N. D., Pirani, C. L., Knowles, D. M. & Appel, G. B. Interstitial nephritis related to nonsteroidal anti-inflammatory agents and β-lactam antibiotics: a comparative study of the interstitial infiltrates using monoclonal antibodies. Modern Pathol. 2, 390–396 (1989).
Border, W. A. et al. Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N. Engl. J. Med. 291, 381–384 (1974).
Pirani, C. L., Valeri, A., D'Agati, V. & Appel, G. B. Renal toxicity of nonsteroidal anti-inflammatory drugs. Contr. Nephrol. 55, 159–175 (1987).
Campese, V. M., Marzullo, F., Schena, F. P. & Coratelli, P. Acute renal failure during intermittent rifampicin therapy. Nephron 10, 256–261 (1973).
Kleinknecht, D. et al. Acute interstitial nephritis due to drug hypersensitivity. An up-to-date review with a report of 19 cases. Adv. Nephrol. Necker Hosp. 12, 277–308 (1983).
Perazella, M. A. Acute renal failure in HIV-infected patients: a brief review of common causes. Am. J. Med. Sci. 319, 385–391 (2000).
Perazella, M. A. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am. J. Med. Sci. 325, 349–362 (2003).
Perazella, M. A. & Tray, K. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs. Am. J. Med. 111, 64–67 (2001).
Schwarz, A., Krause, P. H., Keller, F., Offermann, G. & Mihatsch, M. J. Granulomatous interstitial nephritis after nonsteroidal anti-inflammatory drugs. Am. J. Nephrol. 8, 410–416 (1988).
Dixit, M. P. et al. Non-steroidal anti-inflammatory drug-associated acute interstitial nephritis with granular tubular basement membrane deposits. Pediatr. Nephrol. 23, 145–148 (2008).
Szalat, A. et al. Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature. Arthritis Rheum. 51, 670–673 (2004).
Esteve, J. B., Launay-Vacher, V., Brocherious, I., Grimaldi, A. & Izzedine, H. COX-2 inhibitors and acute interstitial nephritis: Case report and review of the literature. Clin. Nephrol. 63, 385–389 (2005).
Alper, A. B., Meleg-Smith, S. & Krane, N. K. Nephrotic syndrome and interstitial nephritis associated with celecoxib. Am. J. Kidney Dis. 40, 1086–1090 (2002).
Markowitz, G. S. et al. Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. Clin. Nephrol. 59, 137–142 (2003).
Brewster, U. C. & Perazella, M. A. Proton pump inhibitors and the kidney: critical review. Clin. Nephrol. 68, 65–72 (2007).
Ruffenach, S. J., Siskind, M. S. & Lien, Y. H. Acute interstitial nephritis due to omeprazole. Am. J. Med. 93, 472–473 (1992).
Geevasinga, N., Coleman, P. L., Webster, A. C. & Roger, S. D. Proton pump inhibitors and acute interstitial nephritis. Clin. Gastroenterol. Hepatol. 4, 597–604 (2006).
Kuzell, W. C. & Gardner, G. M. Salicylazosulfapyridine (salazopyrin or azopyrin) in rheumatoid arthritis and experimental polyarthritis. Calif. Med. 73, 476–480 (1950).
Moss, A. C. & Peppercorn, M. A. The risks and the benefits of mesalazine as a treatment for ulcerative colitis. Expert Opin. Drug Saf. 6, 99–107 (2007).
World, M. J., Stevens, P. E., Ashton, M. A. & Rainford, D. J. Mesalamine-associated interstitial nephritis. Nephrol. Dial. Transplant. 11, 614–621 (1996).
Arend, L. J. & Springate, J. E. Interstitial nephritis from mesalamine: case report and literature review. Pediatr. Nephrol. 19, 550–553 (2004).
Gisbert, J. P., González-Lama, Y. & Maté, J. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systemic review. Inflamm. Bowel Dis. 13, 629–638 (2007).
Elseviers, M. M. et al. Renal impairment in patients with inflammatory bowel disease: Association with aminosalicylate therapy? Clin. Nephrol. 61, 83–89 (2004).
Corrigan, G. & Stevens, P. E. Interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Aliment. Pharmacol. Ther. 14, 1–6 (2000).
Hiroaka, M. et al. Ultrasonographic findings of acute interstitial nephritis. Am. J. Nephrol. 16, 154–158 (1996).
Linton, A. L. et al. 67Gallium scintigraphy in the diagnosis of acute renal disease. Clin. Nephrol. 24, 84–87 (1985).
Graham, G. D., Lundy, M. M. & Moreno, J. J. Failure of 67Gallium scintigraphy to identify reliably non-infectious interstitial nephritis. J. Nucl. Med. 24, 568–570 (1983).
Laberke, H. G. & Bohle, A. Acute interstitial nephritis: correlations between clinical and morphological findings. Clin. Nephrol. 14, 263–273 (1980).
Pusey, C. D. et al. Drug associated acute interstitial nephritis: clinical and pathological features and the response to high dose steroid therapy. Q. J. Med. 52, 194–211 (1983).
Gonzalez, E. et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 73, 940–946 (2008).
Preddie, D. C. et al. Mycophenylate mofetil for the treatment of interstitial nephritis. Clin. J. Am. Soc. Nephrol. 1, 718–722 (2006).
We would like to thank G. Fogazzi, Research Laboratory on Urine, Unità Operativa di Nefrologia, Fondazione IRCCS, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy for his kind contribution of Figure 1 for this article.
The authors declare no competing financial interests.
About this article
Cite this article
Perazella, M., Markowitz, G. Drug-induced acute interstitial nephritis. Nat Rev Nephrol 6, 461–470 (2010). https://doi.org/10.1038/nrneph.2010.71
Acute interstitial nephritis associated with ingestion of Achyranthes japonica extract: a case report
BMC Nephrology (2021)
Investigational New Drugs (2021)
International Urology and Nephrology (2021)
Analysis of the association between emergency dialysis start in patients with end-stage kidney disease and non-steroidal anti-inflammatory drugs, proton-pump inhibitors, and iodinated contrast agents
Journal of Nephrology (2021)
Elevation of erythrocyte sedimentation rate and C-reactive protein levels reflects renal interstitial inflammation in drug-induced acute tubulointerstitial nephritis
BMC Nephrology (2020)